Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 sept. 2026 08h00 HE | Source: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution

NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
16 sept. 2026 08h00 HE | Source: NeOnc Technologies Holdings, Inc.

NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results

NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
14 août 2026 04h05 HE | Source: Research and Markets

As Acasti Pharma Advances FDA Orphan-Designated GTX-102 Oral Mucosal Spray, New Report Maps 7MM Ataxia-Telangiectasia Treatment Landscape

Dublin, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The "Ataxia Telangiectasia - Market Insight, Epidemiology, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering. The "Ataxia...
12 août 2026 08h00 HE | Source: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma

NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
11 août 2026 08h00 HE | Source: Gibson Oncology LLC

Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma

Gibson Oncology announces first patient completes initial treatment cycle in Phase 2 trial of LMP744 for recurrent glioblastoma
10 août 2026 09h00 HE | Source: NeOnc Technologies Holdings, Inc.

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

NeOnc (NTHI) Q2 2026 Financial Results
18 mai 2026 05h39 HE | Source: Research and Markets

Nanotechnology in Drug Delivery Business Research Report 2026-2032: Market to Reach $161 Billion - Patent Expirations of Blockbuster Drugs Puts Spotlight on Nanodelivery as a Differentiation Strategy

Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Nanotechnology in Drug Delivery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
15 mai 2026 04h23 HE | Source: Research and Markets

CNM-Au8 Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "CNM-Au8 Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering.The report encompasses CNM-Au8's MoA,...
15 mai 2026 04h21 HE | Source: Research and Markets

Dementia Associated With Alzheimer's Disease Market Research Report 2026: Overview of Over 80 Companies and More Than 100 Pipeline Drugs

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Dementia Associated With Alzheimer'S Disease - Pipeline Insight, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a...
04 mars 2026 06h59 HE | Source: Research and Markets

$80+ Bn Drug Delivery Systems Markets - Global Forecast 2026-2032

Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Drug Delivery Systems Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The global drug delivery...

Page suivante